|
Mumbai: Drug maker Cipla Ltd on Tuesday said it has raised Rs 675.99 crore by allotting over 2.56 crore equity shares to qualified institutional buyers on preferential basis.
The duly authorised Committee of Directors (CoD) allotted the equity shares at its meeting held on Tuesday, Cipla informed the Bombay Stock Exchange in a regulatory disclosure.
The committee allotted 2,56,30,000 fully paid-up equity shares of Rs 2 each at an issue price of Rs 263.75 including a premium of Rs 261.75 per piece, it said.
The equity shares were allotted to qualified institutional bidders under the terms of qualified institutional placement as per SEBI guidelines, it said.
The company is focused on developing new drug formulations for existing and active drug substances.
Shares of the company closed at Rs 279.85, up 4.73 per cent from previous close on the BSE.
More from Health & Pharma
Discuss this story on expressindia forums
|
|
 |
 |
 |
About Us | Contact Us | Advertisers | Site Map | Make us your homepage | Work for Us | RSS | Subscribe | Electronic Edition | Privacy Policy© 2010: The Indian Express Limited. All rights reserved throughout the world
